background: 63tpreeclampsia63t is one of the 63tcommon complications63t 63tduring63t 63tpregnancy with63t 63tconsiderable maternal and fetal63t 63tmortality63t 63tand63t 63tmorbidity63t. 63thypercoagulability63t 63tdue to63t 63tthrombophilic63t 63tfactors63t 63tis63t 63tdiscussed as the etiology involved in63t 63tthis disease63t. objective: 63tthe aim of this study63t was to evaluate 63tselecte...

Although venous thrombosis has been traditionally associated with stasis and hypercoagulability, arterial thrombosis is mainly associated with heightened platelet reactivity and damage to the vessel wall. Accordingly, classic risk factors for venous and arterial thrombosis are usually considered distinct. Those for the former include cancer, surgery, pregnancy, and estrogens use, whereas risk f...

retinal vein occlusion (rvo) is a common retinal vascular occlusive disorder and is associated with a variety of systemic risk factors. the aim of this study was to investigate whether the underlying diseases were evaluated and managed appropriately by ophthalmologists. we performed a study of 1344 patients with retinal vein occlusion (rvo). patients were evaluated with a questionnaire includin...

Thrombotic Thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathic disease, associated with thrombocytopenia and hemolytic anemia. It is caused by an enzymatic dysfunction responsible in cleavage of blood clotting factors. In this study we have tried to review the available approaches in diagnoses of the disease as well as treatment strategies. Based on the what the current review ...

Much research in venous thrombotic diseases focuses on the acute thrombotic process such as anticoagulation and risk factors. Deep-vein thrombosis directly leads to post thrombotic syndrome, and this can cause significant patient disability. Little research has focused on the vein wall injury response to the thrombotic inflammatory insult. Herein, we review what is currently known about this pr...

CONTEXT Data on the recurrence rate of venous thrombotic events and the effect of several risk factors, including thrombophilia, remain controversial. The potential benefit of screening for thrombophilia with respect to prophylactic strategies and duration of anticoagulant treatment is not yet known. OBJECTIVES To estimate the recurrence rate of thrombotic events in patients after a first thr...